Position in ABSI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$93,847,799
+$71,873,225 QoQ
Shares Held
8,097,308
+10.5% QoQ
Ownership
4.72%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. ABSI ranks #83 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,847,799 | 8,097,308 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $21,974,574 | 7,324,858 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,908,160 | 5,990,877 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,277,451 | 2,064,951 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,633,902 | 1,803,075 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,192,570 | 1,670,347 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,285,221 | 2,017,260 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,367,817 | 1,928,748 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,997,317 | 1,947,181 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,529,987 | 269,364 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $936,028 | 222,864 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $251,940 | 190,864 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $347,113 | 228,364 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,971,438 | 1,126,536 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,104,382 | 1,002,087 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,090,953 | 987,525 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,074,950 | 926,190 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,076,251 | 720,789 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,970,320 | 240,283 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,901,679 | 163,515 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||